Entera Bio
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $42 | $57 | $0 | $4,482 |
Gross Profit | 0 | 9 | -13 | 4,469 |
EBITDA | -3,010 | -2,154 | -2,049 | -1,950 |
EBIT | -3,021 | -2,165 | -2,062 | -1,963 |
Net Income | 3,021 | -2,145 | -2,017 | -1,995 |
Net Change In Cash | 42 | 57 | 0 | 4,482 |
Free Cash Flow | 5,204 | -1,308 | -1,862 | -2,513 |
Cash | 6,915 | 9,134 | 9,259 | 11,019 |
Basic Shares | 37,644 | 37,090 | 36,735 | 29,704 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $14 | $134 | $571 | $365 |
Gross Profit | -56 | 33 | 198 | 156 |
EBITDA | -8,804 | -12,953 | -12,164 | -10,908 |
EBIT | -8,860 | -13,017 | -12,217 | -11,133 |
Net Income | -8,889 | -13,071 | -12,187 | -9,983 |
Net Change In Cash | 14 | 134 | 571 | 365 |
Free Cash Flow | -7,327 | -12,546 | -9,080 | -10,476 |
Cash | 11,019 | 12,309 | 24,892 | 8,593 |
Basic Shares | 29,007 | 28,808 | 26,133 | 18,417 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.08 |
2024-06-30 | -$0.06 |
2024-03-31 | -$0.05 |
2023-12-31 | -$0.07 |
